Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan flag Japan · Delayed Price · Currency is JPY
2,446.00
+13.50 (0.55%)
Nov 10, 2026, 3:30 PM JST

Ono Pharmaceutical Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Ono Pharmaceutical stock has a consensus rating of "Hold" and an average price target of ¥2,513. The average 1-year stock price forecast is 2.72% higher than the current stock price, while the lowest is ¥1,900 (-22.32%) and the highest is ¥3,200 (+30.83%).

Price Target: ¥2,513 (+2.72%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price¥1,900¥2,513¥2,450¥3,200
Change-22.32%+2.72%+0.16%+30.83%
* Price targets were last updated on Aug 14, 2026.

Analyst Ratings

The average analyst rating for Ono Pharmaceutical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy122222
Buy011111
Hold866666
Sell111111
Strong Sell222222
Total121212121212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Sell
Maintains
¥2,200
SellMaintains¥2,200-10.06%Aug 14, 2026
Jefferies
Jefferies
Hold
Maintains
¥2,500
HoldMaintains¥2,500+2.21%May 29, 2026

Financial Forecast

Revenue This Year
461.08B
from 515.79B
Decreased by -10.61%
Revenue Next Year
448.20B
from 461.08B
Decreased by -2.79%
EPS This Year
159.57
from 148.42
Increased by 7.52%
EPS Next Year
136.55
from 159.57
Decreased by -14.43%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
361.36B447.19B502.67B486.87B515.79B461.08B
Revenue Growth
16.84%23.75%12.41%-3.14%5.94%-10.61%
Gross Profit
267.85B337.13B375.55B338.92B374.07B352.26B
Gross Margin
74.12%75.39%74.71%69.61%72.52%76.40%
Operating Income
110.82B150.05B160.30B61.79B96.89B99.23B
Net Income
80.52B112.72B127.98B50.05B69.77B75.38B
EPS
162.16230.79266.57106.41148.42159.57
EPS Growth
7.33%42.32%15.50%-60.08%39.48%7.52%
Forward PE
13.4910.8110.2411.1217.3115.33
Dividend / Share
56.0070.0080.0080.0080.0080.00
Dividend Growth
12.00%25.00%14.29%---
Free Cash Flow
----96.96B113.95B
No. Analysts
-----5
Financial currency is JPY.

Revenue Forecast

Revenue202720282029
High466.2B
Avg461.1B
Low456.2B

Revenue Growth

Revenue Growth202720282029
High
-9.6%
Avg
-10.6%
Low
-11.5%

EPS Forecast

EPS202720282029
High165.76
Avg159.57
Low150.50

EPS Growth

EPS Growth202720282029
High
11.7%
Avg
7.5%
Low
1.4%